Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · Real-Time Price · USD

5.96

+0.10 (1.71%)

At close: Mar 23, 2026, 4:00 PM EDT

5.72

-0.24 (-4.00%)

After-hours: Mar 23, 2026, 5:16 PM EDT

Champions Oncology Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Champions Oncology in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Champions Oncology.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	2	2	1	1	1
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Maintains $8 → $12	Strong Buy	Maintains	$8 → $12	+101.34%	Mar 12, 2025
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Maintains $6 → $8	Strong Buy	Maintains	$6 → $8	+34.23%	Dec 12, 2024
Matt Hewitt Craig-Hallum	Craig-Hallum	Hold → Strong Buy Upgrades $6	Hold → Strong Buy	Upgrades	$6	+0.67%	Sep 12, 2024
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Mar 13, 2024
Scott Henry Roth MKM	Roth MKM	Strong Buy Maintains $9 → $7.5	Strong Buy	Maintains	$9 → $7.5	+25.84%	Sep 22, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

59.70M

from 56.94M

4.84%

from 56.94M

Revenue Next Year

66.57M

from 59.70M

11.51%

from 59.70M

EPS This Year

0.12

from 0.33

-62.91%

from 0.33

EPS Next Year

0.10

from 0.12

-16.67%

from 0.12

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Apr 30, 2021	Apr 30, 2022	Apr 30, 2023	Apr 30, 2024	Apr 30, 2025	Apr 30, 2026	Apr 30, 2027
Revenue	41.04M	49.11M	53.87M	50.16M	56.94M	59.70M	66.57M
Revenue Growth	27.76%	19.66%	9.70%	-6.90%	13.54%	4.84%	11.51%
EPS	0.02	0.04	-0.39	-0.54	0.33	0.12	0.10
EPS Growth	-	100.01%	-	-	-	-62.91%	-16.67%
Forward PE	-	-	-	-	-	48.69	58.43
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	61.5M	68.5M
Avg	59.7M	66.6M
Low	57.4M	64.0M

Revenue Growth

Revenue Growth	2026	2027
High	7.9%	14.8%
Avg	4.8%	11.5%
Low	0.7%	7.1%

EPS Forecast

EPS	2026	2027
High	0.13	0.11
Avg	0.12	0.10
Low	0.12	0.10

EPS Growth

EPS Growth	2026	2027
High	-61.8%	-14.2%
Avg	-62.9%	-16.7%
Low	-64.4%	-19.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.